AptarGroup, Inc.
NYSE:ATRMedical - Instruments & Supplies
+$0.66 today
- Market cap
- $8.98B
- Beta
- 0.40
- P/E (TTM)
- 20.0
- EPS (TTM)
- $6.04
- Dividend yield
- 1.57%
Volume 0.34M
Average 0.51M
ATR Sales of Investments
Cash received from selling or redeeming investments.
AptarGroup, Inc.NYSE: ATR
Sales of Investments · Q2 FY2026 · quarter ended Jun 2026
Sales of investments outflow grows to $6K
Q2 FY2026 sales of investments was $6K, compared with $0 a year earlier. Trailing-twelve-month sales of investments was $2.96M. Over 3 fiscal years it compounded at +35.1% a year.
Context
- Sales of investments amounted to 0.2% of revenue in FY2025, up 0.2 pp from a year earlier.
- Sales of investments increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly sales of investments holds near $6K or moves back toward the trailing-twelve-month quarterly average of $739.25K.
Sources:Cash FlowText generated from reported figures; not investment advice.
Sales of Investments history
USD · from the cash flow
- Latest · FY2025
- 5.77M USD
- Year-over-year change
- —
- 4-year CAGR
- +24.1%
| Period | Period end | Sales of Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 5.77M | — |
| FY2024 | 2024-12-31 | 0 | -100.0% |
| FY2023 | 2023-12-31 | 5.6M | +139.6% |
| FY2022 | 2022-12-31 | 2.34M | -3.9% |
| FY2021 | 2021-12-31 | 2.43M | — |
Sales of Investments vs competitors
How ATR compares with its peers on the latest reported figures
- Peers report in different currencies, so sales of investments is compared through growth and share of revenue rather than absolute size.
- Sales of investments amounts to 0.1% of revenue for ATR, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $2.96M USD | — | +35.1% | 0.1% | |
| LTM Jun 2026 | €20.02K EUR | -103.9% | +98.1% | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | -100.0% | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding ATR) | — | -101.9% | +98.1% | 0.0% | |
Competitors are the stored peer set for ATR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 243.64M | 239.56M | 284.18M | 374.18M | 392.79M |
| Depreciation & Amortization | 234.85M | 233.71M | 248.59M | 263.78M | 287.36M |
| Deferred Income Tax | (14.36M) | (12.11M) | (19.88M) | (21.41M) | (11.69M) |
| Stock-Based Compensation | 38.87M | 40.94M | 41.29M | 47.65M | 0 |
| Change in Working Capital | (169.7M) | (45M) | 5.75M | (32.26M) | (125.45M) |
| Accounts Receivables | (123.25M) | (27.94M) | 15.43M | (18.08M) | (73.89M) |
| Inventory | (79.96M) | (60.35M) | (10.64M) | 21.9M | (10.65M) |
| Accounts Payables | 52.31M | 55.1M | 14.6M | (23.71M) | (18.27M) |
| Other Working Capital | (18.79M) | (11.8M) | (13.64M) | (12.38M) | (22.64M) |
| Other Non-Cash Items | 30.13M | 21.52M | 15.31M | 11.47M | 26.99M |
| Operating Cash Flow | 363.44M | 478.62M | 575.24M | 643.41M | 570M |
| Capital Expenditures | (307.94M) | (315.62M) | (318.4M) | (294.19M) | (270.42M) |
| Acquisitions (Net) | (148.42M) | (4.1M) | (16.57M) | 0 | (55.87M) |
| Purchases of Investments | (7.37M) | 0 | 0 | (101.3M) | (8.66M) |
| Sales of Investments | 2.43M | 2.34M | 5.6M | 0 | 5.77M |
| Other Investing Activities | 4.05M | 21.74M | 4.91M | (1.23M) | 3.56M |
| Investing Cash Flow | (457.24M) | (295.64M) | (324.46M) | (396.72M) | (330.64M) |
| Debt Repayment | 36.95M | 4.99M | (51.55M) | (97.46M) | 388.64M |
| Common Stock Issued | 0 | 0 | 0 | 0 | 18.89M |
| Common Stock Repurchased | (78.15M) | (92.13M) | (47.55M) | (68.64M) | (365.01M) |
| Dividends Paid | (98.51M) | (99.46M) | (103.68M) | (114.06M) | (120.78M) |
| Other Financing Activities | 58.19M | 24.5M | 31.23M | 54.81M | 0 |
| Financing Cash Flow | (81.52M) | (162.1M) | (171.55M) | (225.34M) | (78.26M) |
| Effect of Forex Changes | (6.73M) | (1.07M) | 2.19M | (21.15M) | 16.98M |
| Net Change in Cash | (182.05M) | 19.81M | 81.41M | 201K | 178.08M |
| Free Cash Flow | 55.51M | 163M | 256.84M | 349.22M | 299.58M |
AptarGroup, Inc.
NYSE:ATR
Intrinsic Alpha fair value
Locked
Current Price
$141.67
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.